BioPlus Acquisition Corp.
CIK 0001856653
Revenue (TTM)
—
Q2 Jun 2023
Net Income (TTM)
$4.25M
+1,523.6% YoY
Q2 Jun 2023
EPS Diluted (TTM)
—
Q2 Jun 2023
Gross Margin
—
Q2 Jun 2023
Operating Margin
—
Q2 Jun 2023
Net Margin
—
Q2 Jun 2023
Free Cash Flow (TTM)
—
Q2 Jun 2023
Cash
$635.54K
Q2 Jun 2023
Total Debt
—
Q2 Jun 2023
Shares Outstanding
—
Q2 Jun 2023
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.